
### [NCIT:C6490](http://purl.obolibrary.org/obo/NCIT_C6490)
**Label:** Benign Fibrohistiocytic Neoplasm

**Subclasses:** [NCIT:C6801](http://purl.obolibrary.org/obo/NCIT_C6801) (Cutaneous Fibrous Histiocytoma), [NCIT:C53963](http://purl.obolibrary.org/obo/NCIT_C53963) (Benign Fibrous Histiocytoma of Bone), [NCIT:C49078](http://purl.obolibrary.org/obo/NCIT_C49078) (Cutaneous Fibrous Histiocytoma, Cellular Variant), [NCIT:C121929](http://purl.obolibrary.org/obo/NCIT_C121929) (Non-Ossifying Fibroma), [NCIT:C49076](http://purl.obolibrary.org/obo/NCIT_C49076) (Cutaneous Fibrous Histiocytoma, Fibroblastic Variant), [NCIT:C129549](http://purl.obolibrary.org/obo/NCIT_C129549) (Intracranial Benign Fibrous Histiocytoma), [NCIT:C35765](http://purl.obolibrary.org/obo/NCIT_C35765) (Histiocytoma), [NCIT:C7343](http://purl.obolibrary.org/obo/NCIT_C7343) (Benign Cutaneous Fibrohistiocytic Neoplasm), [NCIT:C6532](http://purl.obolibrary.org/obo/NCIT_C6532) (Tenosynovial Giant Cell Tumor, Localized Type), [NCIT:C6492](http://purl.obolibrary.org/obo/NCIT_C6492) (Deep Benign Fibrous Histiocytoma), [NCIT:C3739](http://purl.obolibrary.org/obo/NCIT_C3739) (Benign Fibrous Histiocytoma), 

**Class expressions from DL-Learner:**

- Thing 52.26%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40155](http://purl.obolibrary.org/obo/NCIT_C40155) (Endometrial Small Cell Carcinoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40154](http://purl.obolibrary.org/obo/NCIT_C40154) (Endometrial Transitional Cell Carcinoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40153](http://purl.obolibrary.org/obo/NCIT_C40153) (Endometrial Mixed Adenocarcinoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40152](http://purl.obolibrary.org/obo/NCIT_C40152) (Serous Endometrial Intraepithelial Carcinoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40151](http://purl.obolibrary.org/obo/NCIT_C40151) (Grade 3 Endometrial Mucinous Adenocarcinoma))) 41.61%
- [CL:0000864](http://purl.obolibrary.org/obo/CL_0000864) (tissue-resident macrophage) and (not ([NCIT:C40150](http://purl.obolibrary.org/obo/NCIT_C40150) (Grade 2 Endometrial Mucinous Adenocarcinoma))) 41.61%


